Annual CFO
-$115.22 M
-$28.05 M-32.18%
December 31, 2023
Summary
- As of February 7, 2025, IDYA annual cash flow from operations is -$115.22 million, with the most recent change of -$28.05 million (-32.18%) on December 31, 2023.
- During the last 3 years, IDYA annual CFO has fallen by -$170.69 million (-307.75%).
- IDYA annual CFO is now -307.75% below its all-time high of $55.46 million, reached on December 31, 2020.
Performance
IDYA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$49.23 M
-$16.35 M-49.73%
September 30, 2024
Summary
- As of February 7, 2025, IDYA quarterly cash flow from operations is -$49.23 million, with the most recent change of -$16.35 million (-49.73%) on September 30, 2024.
- Over the past year, IDYA quarterly CFO has dropped by -$25.49 million (-107.32%).
- IDYA quarterly CFO is now -154.58% below its all-time high of $90.21 million, reached on September 30, 2020.
Performance
IDYA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$149.68 M
-$19.06 M-14.59%
September 30, 2024
Summary
- As of February 7, 2025, IDYA TTM cash flow from operations is -$149.68 million, with the most recent change of -$19.06 million (-14.59%) on September 30, 2024.
- Over the past year, IDYA TTM CFO has dropped by -$34.45 million (-29.90%).
- IDYA TTM CFO is now -356.50% below its all-time high of $58.35 million, reached on September 30, 2020.
Performance
IDYA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IDYA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.2% | -107.3% | -29.9% |
| 3 y3 years | -307.8% | -107.3% | -29.9% |
| 5 y5 years | -317.2% | -415.8% | -283.1% |
IDYA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.6% | at low | -195.6% | at low | -168.3% | at low |
| 5 y | 5-year | -307.8% | at low | -154.6% | at low | -356.5% | at low |
| alltime | all time | -307.8% | at low | -154.6% | at low | -356.5% | at low |
IDEAYA Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$49.23 M(+49.7%) | -$149.68 M(+14.6%) |
| Jun 2024 | - | -$32.88 M(-24.9%) | -$130.62 M(-0.4%) |
| Mar 2024 | - | -$43.81 M(+84.5%) | -$131.19 M(+13.9%) |
| Dec 2023 | -$115.22 M(+32.2%) | -$23.75 M(-21.3%) | -$115.22 M(+0.3%) |
| Sep 2023 | - | -$30.17 M(-9.8%) | -$114.85 M(+5.5%) |
| Jun 2023 | - | -$33.46 M(+20.2%) | -$108.84 M(+14.1%) |
| Mar 2023 | - | -$27.84 M(+19.1%) | -$95.37 M(+9.4%) |
| Dec 2022 | -$87.17 M(+56.3%) | -$23.37 M(-3.3%) | -$87.17 M(+8.3%) |
| Sep 2022 | - | -$24.17 M(+20.9%) | -$80.46 M(+17.0%) |
| Jun 2022 | - | -$19.99 M(+1.8%) | -$68.76 M(+11.4%) |
| Mar 2022 | - | -$19.65 M(+18.0%) | -$61.70 M(+10.6%) |
| Dec 2021 | -$55.78 M | -$16.66 M(+33.6%) | -$55.78 M(+10.0%) |
| Sep 2021 | - | -$12.47 M(-3.6%) | -$50.72 M(-197.6%) |
| Jun 2021 | - | -$12.93 M(-5.8%) | $51.96 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$13.72 M(+18.4%) | $51.28 M(-7.5%) |
| Dec 2020 | $55.46 M(-241.1%) | -$11.60 M(-112.9%) | $55.46 M(-5.0%) |
| Sep 2020 | - | $90.21 M(-763.0%) | $58.35 M(-237.6%) |
| Jun 2020 | - | -$13.61 M(+42.5%) | -$42.41 M(+8.5%) |
| Mar 2020 | - | -$9.54 M(+9.6%) | -$39.07 M(-0.6%) |
| Dec 2019 | -$39.31 M(+42.3%) | -$8.71 M(-17.5%) | -$39.31 M(+3.2%) |
| Sep 2019 | - | -$10.55 M(+2.7%) | -$38.08 M(+5.1%) |
| Jun 2019 | - | -$10.27 M(+5.0%) | -$36.23 M(+13.6%) |
| Mar 2019 | - | -$9.79 M(+30.9%) | -$31.88 M(+15.4%) |
| Dec 2018 | -$27.62 M(+125.9%) | -$7.48 M(-14.0%) | -$27.62 M(+37.1%) |
| Sep 2018 | - | -$8.69 M(+46.7%) | -$20.14 M(+75.9%) |
| Jun 2018 | - | -$5.93 M(+7.2%) | -$11.45 M(+107.2%) |
| Mar 2018 | - | -$5.53 M | -$5.53 M |
| Dec 2017 | -$12.22 M | - | - |
FAQ
- What is IDEAYA Biosciences annual cash flow from operations?
- What is the all time high annual CFO for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual CFO year-on-year change?
- What is IDEAYA Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly CFO year-on-year change?
- What is IDEAYA Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for IDEAYA Biosciences?
- What is IDEAYA Biosciences TTM CFO year-on-year change?
What is IDEAYA Biosciences annual cash flow from operations?
The current annual CFO of IDYA is -$115.22 M
What is the all time high annual CFO for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual cash flow from operations is $55.46 M
What is IDEAYA Biosciences annual CFO year-on-year change?
Over the past year, IDYA annual cash flow from operations has changed by -$28.05 M (-32.18%)
What is IDEAYA Biosciences quarterly cash flow from operations?
The current quarterly CFO of IDYA is -$49.23 M
What is the all time high quarterly CFO for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly cash flow from operations is $90.21 M
What is IDEAYA Biosciences quarterly CFO year-on-year change?
Over the past year, IDYA quarterly cash flow from operations has changed by -$25.49 M (-107.32%)
What is IDEAYA Biosciences TTM cash flow from operations?
The current TTM CFO of IDYA is -$149.68 M
What is the all time high TTM CFO for IDEAYA Biosciences?
IDEAYA Biosciences all-time high TTM cash flow from operations is $58.35 M
What is IDEAYA Biosciences TTM CFO year-on-year change?
Over the past year, IDYA TTM cash flow from operations has changed by -$34.45 M (-29.90%)